Bernard Lim, B.Sc. (Hons.)

Bernard Lim

Bernard is a senior executive and board leader with over 25 years of experience across biotechnology, diagnostics, medical devices, and high-technology companies in North America and Europe. He helps management teams sharpen strategy, scale operations, and develop talent to expand into new markets.

As founder and chief executive officer of a drug delivery company, he led its development from research through commercialization, rapid growth, and acquisition by Eli Lilly. As Board Chair of Acuity Insights (formerly Altus Assessments) he guided its transition from a university-based initiative to an independent company, helping establish it as a market leader in the United States and Canada.

Bernard currently leads strategic operations as chief operating officer of Cardiol Therapeutics, which develops anti-inflammatory therapies for cardiovascular disease. He is also Board Chair of Front Line Medical Technologies, a vascular trauma company, advises university technology transfer offices and innovation accelerators, and serves as an independent reviewer for life science investment funds.

Keep Reading